Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Dupilumab effectively treated severe alopecia areata in a child.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Rituximab improved her dermatomyositis better than usual treatments.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

The rash resolved after stopping ponatinib.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Immunoadsorption successfully treated a man's resistant polymyositis.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Biological therapy boosts the immune system to effectively fight melanoma.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.